comparemela.com

Latest Breaking News On - டாட் பூர்ணெஒக்ஷ - Page 1 : comparemela.com

Supersapiens : World s First Real-Time Glucose Monitoring for Sports Performance

, a Bluetooth-compatible, real-time data app, developed what it hopes is the latest breakthrough in sports continuous glucose monitoring (CGM). In fact, the sports tech company this week announced it had secured $13.5 million in venture capital funding to develop product. Could CGM biosensors be the next trend in fitness wearables? We already measure our caloric intake, heart rate, rate of oxygen consumption, calories burned before, during, and after exercise so why not glucose, too? A cyclist wearing the Abbott CGM biosensor “Using the Abbott Libre Sense Biosensor and the compatible Supersapiens app, you’re able to understand the fuel your body responds best to, so you can determine your personalized glucose response and fueling strategy,” Supersapiens states.

Supersapiens Closes $13 5 Million in Early-Stage Funding

Share this article Share this article ATLANTA, April 27, 2021 /PRNewswire/ Supersapiens announces a $13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbott s Libre Sense Glucose Sport Biosensor, has secured the largest investment in the sports continuous glucose monitoring (CGM) space, garnering investment from preeminent fitness and performance brands including the founder of Zwift and Wahoo. Supersapiens Closes $13.5 Million in Early-Stage Funding Joining lead investor Michael Hartweg, founder of MICA Ventures AG, is Ed Baker, former VP of product and growth at Uber and head of international growth at Facebook, Harvey Schwartz, former co-president and CFO of Goldman Sachs, Rémi Duchemin, co-founder of OC Sport, and Eric Min, founder and CEO of Zwift. Supersapiens also attracted global investment from CM Ventures, Rubix Ventures, Swiss Startup Group, and Wahoo Fitness.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.